What are the major factors driving the growth of the injectable drugs for Type-2 diabetes market?

Injectable Drugs for Type-2 Diabetes Market size is expected to expand at significant growth rate during the forecast period i.e., between 2025-2037. Read More

What would be the CAGR of injectable drugs for Type-2 diabetes Market over the forecast period?

Injectable Drugs for Type-2 Diabetes Market size is expected to expand at significant growth rate during the forecast period i.e., between 2025-2037.. Read More

Injectable Drugs For Type-2 Diabetes Market Trends

Growth Driver

Growing Diabetes Vulnerable Population to Drive Market

With increasing life expectancy and birth rate declining, median age of the world population is expected to rise. Old age people are generally more vulnerable towards diabetes, thereby the number of people with type 2 diabetes are expected to rise and hence provide an opportunity of the injectable drugs for type 2 diabetes market to grow.

Increasing Prevalence of Type 2 Diabetes to Boost Market Growth for Injectable Drugs

Type 2 diabetes is progressive in nature and its prevalence is increasing leading to the need of suitable treatment to fulfil the unmet needs of the body of patient. Injectable drugs serve as an option to fulfil those needs and it will drive the market growth in the forecast period.

Increasing Awareness About Type 2 Diabetes to Drive Market Growth

Organizations such as the International Diabetes Federation (IDF) conduct various community-level and global-level programs that focus on educating people and enhancing their knowledge about diabetes and its management. Globally, the World Diabetes Day is celebrated on November 14 by over 200 member associations of the IDF. Such programs will make people more aware about diabetes and will provide them knowledge to manage it in a better way using various kind of drugs available in the injectable drugs for type-2 diabetes market.

Restraints

Stringent Regulation Environment to Hamper Market Growth

In an effort to protect public from harmful drug effects, governments make rule and regulations stringent. Usually government regulations make product development more expensive. Such environment can create a hindrance in the market growth in that region.

Time Consuming Approval Process of Drugs to Restrain Market Growth

From the time of research and development to the official launch of drugs, it takes a very long time. Even after development and successful trials, approval from regulatory authority takes a lot of time and a lot of entrepreneurs and big players do not invest in drug manufacturing due to this reason. Over the forecast period this may hamper the growth of injectable drug for type 2 diabetes market.

Injectable Drugs for Type-2 Diabetes Market: Key Insights

Global injectable drugs for type-2 diabetes market is anticipated to record a significant CAGR over the forecast period, i.e., 2020-2028. The primary factor for the growth of the market can be attributed to the increase in prevalence of type 2 diabetes globally. According to NCBI (National Center for Biotechnology Information), number of people affected by diabetes mellitus is expected to reach to a figure of more than 600 million. Additionally, type 2 diabetes mellitus account for nearly 90% of all diabetes cases. Owing to this rise in diabetic patients, the market for injectable drugs for type 2 diabetes is anticipated to grow significantly.

The market is further segmented by drug type, drug application, distribution channel and region. The drug type segment is further divided into insulin, exenatide, liragultide and pramlintide. Segments other than insulin are relatively new to the market and they are expected to show moderate growth on the back of their rising awareness. In terms of application, these drugs are most commonly used for glycemic control owing to the requirement of sugar control in blood of the diabetes patients. Moreover, according to NCBI are more vulnerable towards type 2 diabetes and with the rise in old age population globally the need for cardiovascular safety rises as well. Additionally, with the increasing popularity of online pharmacies the supply chain in the field of drug delivery is expected to improve tremendously. On the back of these factors the global injectable drug for type 2 diabetes market is expected to grow notably over the forecast period.

Base Year	2024
Forecast Year	2025-2037
CAGR
Base Year Market Size (2024)
Forecast Year Market Size (2037)
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Who are the key players in the injectable drugs for Type-2 diabetes sector?

The major players in the market are AstraZeneca Plc., GlaxoSmithKline Plc., Merck & Co., Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Pfizer Inc., Novo Nordisk A/S, Sanofi, Eli Lilly and Company, and others.

Injectable Drugs For Type-2 Diabetes Market Trends